Provided is a composition for preventing or treating damages of the mucosa in the gastrointestinal tracts, comprising revaprazan or a salt thereof and a pharmaceutically acceptable carrier. Revaprazan or its salt has an excellent preventive or treatment effect for gastrointestinal mucosal damage by potentiating a defensive factor in the gastrointestinal mucosa, simultaneously with acting as an acid pump antagonist.